LÃ¶hle M	FIS_74892
Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications.
Putaminal Dopamine Turnover in de novo Parkinson's Disease Predicts Later Neuropsychiatric Fluctuations but Not Other Major Health Outcomes.
Olfactory dysfunction correlates with putaminal dopamine turnover in early de novo Parkinson's disease.
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.